GlaxoSmithKline Consumer Healthcare Q4 '06 PAT up by 17.9%, Gurgaon, Jan 31, 2007
31 January 2007
GlaxoSmithKline Consumer Healthcare achieves 11.5% sales growth
2006 PAT up by 18.4%
Gurgaon, January 31, 2007: GlaxoSmithKline Consumer Healthcare Limited (GSKCH), a global nutritional healthcare company present in India since 1958, today declared its financial results for the year ended December 31, 2006. Sales stood at Rs. 1,214.3 crore with the company achieving a double digit sales growth of 11.5% over 2005. PAT grew by 18.4% over last year to Rs. 126.9 crore and PBT grew by 17.3% over last year to Rs. 190.6 crore.
"2006 has been a year of strong all-round performance for the business", said Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd. "I am pleased to state that we've achieved a double digit sales growth over 2005 with our key brands Horlicks and Boost doing well in line with our expectations. This has been as a result of a strong focus on consumer-centric innovation and brand support. Unprecedented rises in input costs continue to be an area of concern. Savings arising out of a well executed in-house cost containment programme have led to a healthy bottom-line growth."
For the quarter ended December 31, sales stood at Rs. 288.9 crore, representing growth of 7.6%. PAT rose 17.9% to Rs. 25.3 crore.
About GlaxoSmithKline Consumer Healthcare Ltd.
GSKCH, which was established in 1958, is an associate of GlaxoSmithKline plc. of the U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is one of the largest players in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2700 people.
GSKCH has a strong marketing and distribution network in India comprising over 1800 wholesalers and direct coverage of over 4,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.
For more information, please contact:
Head of Communications, GlaxoSmithKline Consumer Healthcare